BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26431626)

  • 1. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
    Dalle JH; Giralt SA
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Farina M; Scaini MC; Facchinetti A; Leoni A; Bernardi S; Catoni C; Morello E; Radici V; Frioni F; Campodonico E; Traverso G; Cavallaro G; Olivieri A; Galieni P; Renzo ND; Patriarca F; Carluccio P; Skert C; Maffini E; Pellizzeri S; Campisi G; Re F; Benedetti E; Rosato A; Almici C; Chiusolo P; Peccatori J; Malagola M; Poggiana C; Russo D
    Transplant Cell Ther; 2024 Jun; 30(6):580.e1-580.e14. PubMed ID: 38582286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.
    Ichikawa H; Yakushijin K; Kurata K; Tsuji T; Takemoto N; Joyce M; Okazoe Y; Takahashi R; Matsumoto S; Sakai R; Kitao A; Miyata Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Murayama T; Matsuoka H; Minami H
    Bone Marrow Transplant; 2024 Apr; 59(4):518-525. PubMed ID: 38287083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.
    Takemura K; Nakamae M; Okamura H; Sakatoku K; Ido K; Makuuchi Y; Kuno M; Takakuwa T; Hirose A; Nishimoto M; Nakashima Y; Koh H; Igarashi K; Kubota H; Hino M; Nakamae H
    Ann Hematol; 2024 May; 103(5):1705-1715. PubMed ID: 38494552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
    Ho VT; Martin AS; Pérez WS; Steinert P; Zhang MJ; Chirnomas D; Hoang CJ; Loberiza FR; Saber W
    Biol Blood Marrow Transplant; 2020 May; 26(5):884-892. PubMed ID: 31891815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
    Inoue Y; Saitoh S; Denpo H; Yamaguchi K; Kubota K; Taya Y; Wake A; Masuda A; Ishiwata K
    J Med Ultrason (2001); 2024 Apr; 51(2):311-321. PubMed ID: 38112930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
    Fan CQ; Crawford JM
    J Clin Exp Hepatol; 2014 Dec; 4(4):332-46. PubMed ID: 25755580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE AFTER UNMANIPULATED HAPLOIDENTICAL HSCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: A STUDY ON BEHALF OF THE SPANISH HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPY GROUP (GETH).
    Gómez-Centurión I; Gallardo Morillo AI; Pérez Martínez A; Cabrero Calvo M; Chinea A; González L; Pedraza A; Jiménez Lorenzo MJ; Robles MC; Bailén R; Cascón MJP; Cabero A; Piñana Sánchez JL; Luna A; Perera Alvarez M; Rovira M; Torrent Catarineu A; Sánchez-Pina J; Kwon M
    Transplant Cell Ther; 2024 Jun; ():. PubMed ID: 38851323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic veno-occlusive disease complicated with extreme hyperammonaemia (920 µmol/L) treated with defibrotide, lactulose, rifampin and haemodialysis.
    Kabat M; Gill S; Kim K; Omidvari K; Lee R
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veno occlusive disease: update on clinical management.
    Senzolo M; Germani G; Cholongitas E; Burra P; Burroughs AK
    World J Gastroenterol; 2007 Aug; 13(29):3918-24. PubMed ID: 17663504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience.
    Kartal İ; Albayrak C; Dağdemir A; Dinçer OS; Şimşek HK; Özgen Ü; Albayrak D
    Transfus Apher Sci; 2024 Jun; 63(3):103909. PubMed ID: 38467529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.
    Richardson PG; Ho VT; Giralt S; Arai S; Mineishi S; Cutler C; Antin JH; Stavitzski N; Niederwieser D; Holler E; Carreras E; Soiffer R
    Ther Adv Hematol; 2012 Aug; 3(4):253-65. PubMed ID: 23606935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of imaging findings in hepatic veno-occlusive disease.
    Simpson S; Breshears E; Basavalingu D; Khatri G; Chan S; Fite J; Swanson P; Dighe M
    Eur J Radiol; 2024 Jun; 177():111526. PubMed ID: 38850721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation.
    Sawyer J; Elliott T; Orton L; Sowell H; Gatwood K; Shultes K
    Clin Hematol Int; 2024; 6(2):1-10. PubMed ID: 38817311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study.
    Ragoonanan D; Abdel-Azim H; Sharma A; Bhar S; McArthur J; Madden R; Rahrig A; Bajwa R; Wang J; Sun V; Wright M; Lassiter R; Shoberu B; Kawedia J; Khazal SJ; Mahadeo KM;
    Lancet Reg Health Am; 2024 May; 33():100728. PubMed ID: 38616918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
    Richardson PG; Riches ML; Kernan NA; Brochstein JA; Mineishi S; Termuhlen AM; Arai S; Grupp SA; Guinan EC; Martin PL; Steinbach G; Krishnan A; Nemecek ER; Giralt S; Rodriguez T; Duerst R; Doyle J; Antin JH; Smith A; Lehmann L; Champlin R; Gillio A; Bajwa R; D'Agostino RB; Massaro J; Warren D; Miloslavsky M; Hume RL; Iacobelli M; Nejadnik B; Hannah AL; Soiffer RJ
    Blood; 2016 Mar; 127(13):1656-65. PubMed ID: 26825712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
    Corbacioglu S; Carreras E; Ansari M; Balduzzi A; Cesaro S; Dalle JH; Dignan F; Gibson B; Guengoer T; Gruhn B; Lankester A; Locatelli F; Pagliuca A; Peters C; Richardson PG; Schulz AS; Sedlacek P; Stein J; Sykora KW; Toporski J; Trigoso E; Vetteranta K; Wachowiak J; Wallhult E; Wynn R; Yaniv I; Yesilipek A; Mohty M; Bader P
    Bone Marrow Transplant; 2018 Feb; 53(2):138-145. PubMed ID: 28759025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
    Mohty M; Malard F; Abecassis M; Aerts E; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Fukuda T; Huynh A; Masszi T; Michallet M; Nagler A; NiChonghaile M; Okamoto S; Pagliuca A; Peters C; Petersen FB; Richardson PG; Ruutu T; Savani BN; Wallhult E; Yakoub-Agha I; Duarte RF; Carreras E
    Bone Marrow Transplant; 2016 Jul; 51(7):906-12. PubMed ID: 27183098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.
    Coutsouvelis J; Avery S; Dooley M; Kirkpatrick C; Spencer A
    Cancer Treat Rev; 2016 Nov; 50():200-204. PubMed ID: 27721142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.